Radiomic signatures associated with tumor immune heterogeneity predict survival in locally recurrent nasopharyngeal carcinoma.
Saved in:
| Title: | Radiomic signatures associated with tumor immune heterogeneity predict survival in locally recurrent nasopharyngeal carcinoma. |
|---|---|
| Authors: | Lin DF; Department of Nasopharyngeal Carcinoma, Sun Yat-sen University Cancer Center, Guangzhou, China.; State Key Laboratory of Oncology in South China, Guangzhou, China.; Collaborative Innovation Center for Cancer Medicine, Guangzhou, China.; Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou, China.; Guangdong Provincial Clinical Research Center for Cancer, Guangzhou, China., Li HL; School of Engineering Medicine, Beihang University, Beijing, China.; Chinese Academy of Sciences Key Laboratory of Molecular Imaging, Institute of Automation, Chinese Academy of Sciences, Beijing, China., Liu T; Department of Nasopharyngeal Carcinoma, Sun Yat-sen University Cancer Center, Guangzhou, China.; State Key Laboratory of Oncology in South China, Guangzhou, China.; Collaborative Innovation Center for Cancer Medicine, Guangzhou, China.; Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou, China.; Guangdong Provincial Clinical Research Center for Cancer, Guangzhou, China.; Department of Breast Surgery, Breast Disease Center, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China., Lv XF; State Key Laboratory of Oncology in South China, Guangzhou, China.; Collaborative Innovation Center for Cancer Medicine, Guangzhou, China.; Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou, China.; Guangdong Provincial Clinical Research Center for Cancer, Guangzhou, China.; Department of Radiology, Sun Yat-sen University Cancer Center, Guangzhou, China., Xie CM; State Key Laboratory of Oncology in South China, Guangzhou, China.; Collaborative Innovation Center for Cancer Medicine, Guangzhou, China.; Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou, China.; Guangdong Provincial Clinical Research Center for Cancer, Guangzhou, China.; Department of Radiology, Sun Yat-sen University Cancer Center, Guangzhou, China., Ou XM; Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China., Guan J; Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, China., Zhang Y; Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China., Yan WB; Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China., He ML; Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China., Mao MY; Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, China., Zhao X; Chinese Academy of Sciences Key Laboratory of Molecular Imaging, Institute of Automation, Chinese Academy of Sciences, Beijing, China.; School of Artificial Intelligence, University of Chinese Academy of Sciences, Beijing, China., Zhong LZ; Chinese Academy of Sciences Key Laboratory of Molecular Imaging, Institute of Automation, Chinese Academy of Sciences, Beijing, China.; School of Artificial Intelligence, University of Chinese Academy of Sciences, Beijing, China., Chen WH; Department of Oncology, The First Affiliated Hospital of Jinan University, Guangzhou, China., Chen QY; Department of Nasopharyngeal Carcinoma, Sun Yat-sen University Cancer Center, Guangzhou, China.; State Key Laboratory of Oncology in South China, Guangzhou, China.; Collaborative Innovation Center for Cancer Medicine, Guangzhou, China.; Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou, China.; Guangdong Provincial Clinical Research Center for Cancer, Guangzhou, China., Mai HQ; Department of Nasopharyngeal Carcinoma, Sun Yat-sen University Cancer Center, Guangzhou, China.; State Key Laboratory of Oncology in South China, Guangzhou, China.; Collaborative Innovation Center for Cancer Medicine, Guangzhou, China.; Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou, China.; Guangdong Provincial Clinical Research Center for Cancer, Guangzhou, China., Peng RJ; State Key Laboratory of Oncology in South China, Guangzhou, China.; Collaborative Innovation Center for Cancer Medicine, Guangzhou, China.; Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou, China.; Guangdong Provincial Clinical Research Center for Cancer, Guangzhou, China.; Department of VIP Inpatient, Sun Yat-sen University Cancer Center, Guangzhou, China., Tian J; School of Engineering Medicine, Beihang University, Beijing, China.; Chinese Academy of Sciences Key Laboratory of Molecular Imaging, Institute of Automation, Chinese Academy of Sciences, Beijing, China.; National Key Laboratory of Kidney Diseases, Beijing, China., Tang LQ; Department of Nasopharyngeal Carcinoma, Sun Yat-sen University Cancer Center, Guangzhou, China.; State Key Laboratory of Oncology in South China, Guangzhou, China.; Collaborative Innovation Center for Cancer Medicine, Guangzhou, China.; Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou, China.; Guangdong Provincial Clinical Research Center for Cancer, Guangzhou, China., Dong D; Chinese Academy of Sciences Key Laboratory of Molecular Imaging, Institute of Automation, Chinese Academy of Sciences, Beijing, China.; School of Artificial Intelligence, University of Chinese Academy of Sciences, Beijing, China.; National Key Laboratory of Kidney Diseases, Beijing, China. |
| Source: | Journal of the National Cancer Institute [J Natl Cancer Inst] 2024 Aug 01; Vol. 116 (8), pp. 1294-1302. |
| Publication Type: | Journal Article; Multicenter Study |
| Journal Info: | Publisher: Oxford University Press Country of Publication: United States NLM ID: 7503089 Publication Model: Print Cited Medium: Internet ISSN: 1460-2105 (Electronic) Linking ISSN: 00278874 NLM ISO Abbreviation: J Natl Cancer Inst Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1460-2105 |
|---|---|
| DOI: | 10.1093/jnci/djae081 |
